Tender notice from Bulgaria, published on 13 Mar 2020.
Executive Summary
The „КОМПЛЕКСЕН ОНКОЛОГИЧЕН ЦЕНТЪР — ВЕЛИКО ТЪРНОВО“ ЕООД has issued a Tender notice for the procurement of a Contract notice: Pharmaceutical products in the Bulgaria. This Tender notice was published on 13 Mar 2020 and is scheduled to close on 09 Apr 2020, with an estimated Tender value of Refer Document.
Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 41512771, while the tender notice number is 122974-2020 and Register on the platform.
Object of the contract Pharmaceutical products Description: Contract notice: Pharmaceutical products Authority Type: Other Contact Nature: Supplies Procedure: Open procedure Document: Contract notice Regulation: European Union Award criteria: Lowest price CPV code: 33600000, 33600000, 33600000 CPV Description: Pharmaceutical products. Delivery of medicines and radiopharmaceuticals for the needs of "KOTS - V. Tarnovo" Ltd. Reference Number: 00763 Delivery of medicines and radiopharmaceuticals for diagnostics and treatment of patients of "KOTS - V. Tarnovo" Ltd. Main Site: Hospital Pharmacy of KOTS - V. Tarnovo Ltd. Item # 1 includes 259 units, each of which is a separate medicine.but a remedy. The medicines are divided into 35 pharmacological groups: 1. Anesthetics - nom. units from 1 to 13 incl. 2. Analgesics - drugs, non-narcotics and antipyretics - nom. units from 14 to 21 incl. 3. Psycholeptics - by nom. units 22 to 27 incl. 4. Nootropic - nom. units 28 and 29. 5. Parasympathomimetics - nom. 30. 6. Drugs for the treatment of peptic ulcer - H 2 receptor antagonists, incproton pump inhibitors - nom. units 31, 32 and 33. 7. Antispasmodics and anticholinergics and peristalsis enhancers - nom. units 34 to 34 incl. 8. Treatment of the liver - nom. units 44, 45 and 46. 9. Cleansers - nom. units 47 and 48. 10. Anti-diarrheal bowel suppressants - nom. units 49 and 50. 11.Endocrine and metabolic preparations, human insulinyin with short action - nom. 51 12. Vitamins - by nom. units 52 to 59 incl. 13. Mineral supplements - from nom. units 60 to 64 incl. 14. Additives for solutions intravenous administration nom. unit 65. 15. Antithrombotic agents - antagonists of Vit. K and a group of heparin - from nom. units 66 to 77 incl. 16. Anthemorrhagic agents - nom. units 78, 79 and 80. 17. Anti-anemic preparations and colonymulching factors - from nom. units 81 to 85 incl. 18. Plasma substitutes and infusion solutions, colloidal solutions - from nom. units 86 to 114 incl. 19. Treatment of heart disease. 19.1. Cardiac glycosides - nom. units 115 and 116. 19.2. Antiarrhythmic - by nom. units 117 to 123 incl. 19.3. Adrenergic and catecholamic preparations - nom. units 124 and 125. 19.4. Antihypertensives - nom.units 126 to 137 incl. 19.5. Antistenocardial agents - nitrates - nom. units 138, 139, and 140. 20. Diuretics - by nom. units 141 to 146 incl. 21. Peripheral vasodilators - nom. units 147, 148, and 149. 22. Dermatologicals - by nom. units 150 to 163 incl. 23. Cortecosteroids for systemic use - from nom. units 164 to 170 incl. 24. Antibacterial agents. 24.1. Antibiotics - by nom. units171 to 204 incl. 24.2. Quinolones - by nom. units 205 to 212 incl. 24.3. Sulfonamides and trimethoprim. 213. 24.4. Antiprotozoal agents - nom. units 214, 215 and 216. 24.5. Antimycotic agents - nom. units 217 and 218. 25. Non-steroidal anti-inflammatory drugs - nom. units 219 to 224 incl. 26. Muscle relaxants - by nom. units 225 to 229 incl. 27. Anti-asthmatic preparations - from nom. edays 230 to 235 incl. 28. Cough and cold medications - nom. units 236 to 239 incl. 29. Antihistamines - nom. units 240, 241, and 242. 30. Other ancillary products - nom. 243. 31. X-ray contrast media - from nom. units 244 to 248 incl. 32. Enteral nutrition - nom. units 249 to 253 incl. 33. Sera and immunoglobulin preparations and vaccineand - nom. units 254 and 255. 34. Calcium-phosphorus and bone metabolism agents - nom. 256. 35. Antidotes - by nom. units 257 to 259 incl. Detailed medicines description - ATC, INN, measure, estimated quantity, is contained in the technical specification published on the buyer profile- http: //www.onkologyvt.com/procurments/04032020-2/ Specific requirement for lesevofluran fl. 250 ml: The participant participating and designated as the contractor for the delivery of Sevofluran fl. 250 ml, undertakes: - to provide free of charge for the duration of the contract evaporators with a filling system compatible with the available equipment at the medical establishment, - present a certificate for calibration of the evaporators, - present a technical protwork safety stake. Participants hold a valid wholesale BDA license for medicinal products issued by the BDA under the LPPMH and a license for drug activity (where applicable), and for non-residents - equivalent documents according to their national legislation. To prove the eligibility criterion of participantson request, and the successful tenderer, prior to the conclusion of the contract, present a valid wholesale marketing authorization for medicinal products and a license for narcotic activities (only for medicinal products with such substances). in the procedure the circumstances under art. 54 and Art. 55, para. 1, item 1 of the Public Procurement Act. Otherwisethe rays are removed from participation. They declare the lack of grounds for removal under Art. 54 and Art. 55, para. 1, item 1 of the Public Procurement Act by submitting the EEDEP when submitting its tender. In case the participant has the circumstance under Art. 55, para. 1, item 1 of the PPA, the same may not be removed if it is proved that he has not ceased his activity and is able to execute the order. Availabilityor the absence of the circumstances for removal under Art. 108 a, Art. 159a - 159 g, Art. 192a, Art. 209 213, Art. 253, Art. 301-307, Art. 321 and 321a of the Criminal Code is declared in section A "Grounds for criminal convictions" in part III "Grounds for exclusion" in the EEOPP. The presence or absence of the circumstances for removal under Art. 172, Art. 194-208, Art. 214-21, Art. 219-252, Art. 352-353 is, Art. 254—260 of the Criminal Code is declared in section D "Other grounds for exclusion which may be provided in nat. legislation of the contracting authority or contracting authority of a Member State "in Part III" Grounds for exclusion "in EEOP. The performance guarantee is 2% of the contract value excluding VAT. The same shall be presented in one of the forms under Art. 111, para. 5 of the PPL. The bank guarantee and the insurance must be validvalidity one month after the term of the contract, and the money guarantee - deposited into the following bank account: IBAN: BG 52 UNCR 9660 10 37 299 411, BIC: UNCRBGSF, UniCredit Bulbank AD, Veliko Tarnovo Branch. Conditions for release of the guarantee For the purposes of this contract, the reverse order for the consideration of tenders in accordance with Article 104 shall apply, para. 2 of the Public Procurement Act and Art. 61 of the PDAB. The selection criteria are the same for all the nomenclatures in them. One application for participation may be submitted if the participant submits an offer for nomenclatures from different positions. Internet address (URL): www.onkologyvt.com
The bid deadline for Contract notice: Pharmaceutical products was 09 Apr 2020. Bidding is closed.
This tender has been issued by „КОМПЛЕКСЕН ОНКОЛОГИЧЕН ЦЕНТЪР — ВЕЛИКО ТЪРНОВО“ ЕООД in Bulgaria.
The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.
This tender is Self Financed
The tender is classified under the following CPV code(s): 33600000 - Pharmaceutical products.
The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.
The TendersOnTime reference is 41512771. The purchaser document reference is 122974-2020.